Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (451-460 of 504) with videos related to

Pageof 51
Sort By:
Gut|February 1, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Zonera Hassan, Christian Schneeweis, et al.
Der Pathologe|December 1, 2020
[Diagnosis and therapy of tumors with NTRK gene fusion]Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnosticsStanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 23, 2019
BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinomaMaria Wiethaler, Julia Slotta-Huspenina, Anna Brandtner, et al.
The Journal of Clinical Investigation|August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrixHonglin Jiang, Robert J Torphy, Katja Steiger, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Nature Communications|January 26, 2017
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancerSoulafa Mamlouk, Liam Harold Childs, Daniela Aust, et al.
Pageof 51

Showing results (451-460 of 504) with videos related to

Sort By:
Pageof 51
Gut|February 1, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Zonera Hassan, Christian Schneeweis, et al.
Der Pathologe|December 1, 2020
[Diagnosis and therapy of tumors with NTRK gene fusion]Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnosticsStanislas Quesada, Frédérique Penault-Llorca, Xavier Matias-Guiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 23, 2019
BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinomaMaria Wiethaler, Julia Slotta-Huspenina, Anna Brandtner, et al.
The Journal of Clinical Investigation|August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrixHonglin Jiang, Robert J Torphy, Katja Steiger, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Nature Communications|January 26, 2017
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancerSoulafa Mamlouk, Liam Harold Childs, Daniela Aust, et al.
Pageof 51